Jiangxi Puheng Pharma

Jiangxi Puheng Pharma is a pharmaceutical company headquartered in Nanchang, China, dedicated to the research, development, and production of high-end generic drugs and active pharmaceutical ingredients (APIs). The company's expertise lies in small molecule synthesis and process chemistry, particularly for complex molecules in the fields of immunology and cardiovascular medicine. Puheng Pharma operates state-of-the-art R&D centers and manufacturing facilities that comply with global GMP standards. Their product portfolio includes generic versions of blockbuster drugs such as Apremilast and Tofacitinib, aimed at providing affordable treatment options for chronic conditions. Additionally, the company offers CDMO services and technical support for drug consistency evaluations.